Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study

BACKGROUND: This study examined 5-year overall, recurrence and distant metastasis-free survival (OS, RFS, MFS) of high- and intermediate-risk breast cancer (BC) patients who declined guideline-recommended adjuvant chemotherapy (CHT). METHODS: In the prospective multicenter cohort study BRENDA II, pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Leinert, Elena, Schwentner, Lukas, Janni, Wolfgang, Wöckel, Achim, Herbert, Saskia-L., Herr, Daniel, Kühn, Thorsten, Flock, Felix, Felberbaum, Ricardo, Kreienberg, Rolf, Fink, Visnja, Dayan, Davut, Ernst, Kristina, Singer, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021155/
https://www.ncbi.nlm.nih.gov/pubmed/35178667
http://dx.doi.org/10.1007/s12282-021-01321-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021155/
https://www.ncbi.nlm.nih.gov/pubmed/35178667
http://dx.doi.org/10.1007/s12282-021-01321-1

Ejemplares similares